A
Ardelyx D
D
ARDX
4.12500
USD
-1.33
(-24.31%)
مغلق
حجم التداول
1,077,946
الربح لكل سهم
-0
العائد الربحي
-
P/E
-24
حجم السوق
983,219,416
الأخبار المقالات
العنوان: Ardelyx
القطاع: Healthcare
الصناعة: Biotechnology
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adultswith IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.